Invention Grant
- Patent Title: Pegylated interleukin-10
- Patent Title (中): 聚乙二醇化白细胞介素-10
-
Application No.: US13218929Application Date: 2011-08-26
-
Publication No.: US08697045B2Publication Date: 2014-04-15
- Inventor: Seoju Lee , David C. Wylie , Susan Cannon-Carlson
- Applicant: Seoju Lee , David C. Wylie , Susan Cannon-Carlson
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corporation
- Current Assignee: Merck Sharp & Dohme Corporation
- Current Assignee Address: US NJ Rahway
- Agency: Bozicevic, Field & Francis LLP
- Agent Carol L. Francis
- Main IPC: A61K38/20
- IPC: A61K38/20 ; A61K31/77 ; A61K47/48 ; A61P29/00 ; C07K14/54 ; C07K17/08

Abstract:
Interleukin-10 (IL-10) conjugated via a linker to one or more polyethylene glycol (PEG) molecules at a single amino acid residue of the IL-10, and a method for preparing the same, are provided. The method produces a stable mono-pegylated IL-10, which retains IL-10 activity, where pegylation is selective for the N-terminus on one subunit of IL-10 with little or no formation of monomeric IL-10. The method also provides a substantially homogenous population of mono-PEG-IL-10.
Public/Granted literature
- US20110305665A1 PEGYLATED INTERLEUKIN-10 Public/Granted day:2011-12-15
Information query
IPC分类: